{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"polr3-related-leukodystrophy","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"POLR3-related leukodystrophy affects myelin, the protective covering around nerves. Its features can involve movement and coordination, tooth development, hormone function and eyesight.","mondoId":"MONDO:0700282","node":{"canonicalSlug":"polr3-related-leukodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"POLR3-Related Leukodystrophy","paragraphs":["POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:","* Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions)\n* Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth)\n* Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty\n* Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe","POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include:","* Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome);\n* Ataxia, delayed dentition, and hypomyelination (ADDH);\n* Tremor-ataxia with central hypomyelination (TACH);\n* Leukodystrophy with oligodontia (LO);\n* Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).","Age of onset is typically in early childhood but later-onset cases have also been reported.","An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in *POLR3A* on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome."],"reviewed":"2017-05-11","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:10:54.640228+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK99167/"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"POLR-related leukodystrophy","mondoId":"MONDO:0100605","slug":"polr-related-leukodystrophy"},{"kind":"child","label":"leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism","mondoId":"MONDO:0011897","slug":"leukodystrophy-hypomyelinating-7-with-or-without-oligodontia-and-or-hypogonadotropic-hypogonadism"},{"kind":"child","label":"leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism","mondoId":"MONDO:0013722","slug":"leukodystrophy-hypomyelinating-8-with-or-without-oligodontia-and-or-hypogonadotropic-hypogonadism"},{"kind":"child","label":"leukodystrophy, hypomyelinating, 11","mondoId":"MONDO:0014666","slug":"leukodystrophy-hypomyelinating-11"},{"kind":"child","label":"leukodystrophy, hypomyelinating, 21","mondoId":"MONDO:0030263","slug":"leukodystrophy-hypomyelinating-21"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Description is a stub or its provenance is unresolved","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/27146"}],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"The list is present in the ingested GeneReviews overview. Restore that overview unchanged and make the abbreviated lede a complete summary.","sources":["https://www.ncbi.nlm.nih.gov/books/NBK99167/"],"originalNarrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"POLR3-Related Leukodystrophy","paragraphs":["POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:","* Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions)\n* Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth)\n* Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty\n* Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe","POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include:","* Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome);\n* Ataxia, delayed dentition, and hypomyelination (ADDH);\n* Tremor-ataxia with central hypomyelination (TACH);\n* Leukodystrophy with oligodontia (LO);\n* Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).","Age of onset is typically in early childhood but later-onset cases have also been reported.","An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in *POLR3A* on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome."],"reviewed":"2017-05-11","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:10:54.640228+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK99167/"},"claimHolds":[]}},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK99167/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700282\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-title</dd><dt>Upstream attribution</dt><dd>GeneReviews clinical characteristics</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK99167/\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:</p><p>* Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions)\n* Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth)\n* Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty\n* Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe</p><p>POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include:</p><p>* Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome);\n* Ataxia, delayed dentition, and hypomyelination (ADDH);\n* Tremor-ataxia with central hypomyelination (TACH);\n* Leukodystrophy with oligodontia (LO);\n* Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).</p><p>Age of onset is typically in early childhood but later-onset cases have also been reported.</p><p>An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in *POLR3A* on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK99167/\" rel=\"noreferrer\">GeneReviews</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"polr3-related-leukodystrophy","sourceDocuments":[{"name":"GeneReviews: POLR3-Related Leukodystrophy","reviewed":"2017-05-11","source_release":"2026-10-18 12:10:54.640228+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK99167/"},{"name":"MONDO: POLR3-related leukodystrophy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0700282"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"POLR3-related leukodystrophy"},"schemaVersion":1}
